5.46 - 5.64
4.95 - 8.28
2.0K / 2.4K (Avg.)
-282.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
9.08%
Positive revenue growth while HUH1V.HE is negative. John Neff might see a notable competitive edge here.
120.47%
Gross profit growth of 120.47% while HUH1V.HE is zero. Bruce Berkowitz would see if minimal improvements could expand further.
26.84%
EBIT growth above 1.5x HUH1V.HE's 7.40%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
26.84%
Operating income growth above 1.5x HUH1V.HE's 7.40%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
28.03%
Positive net income growth while HUH1V.HE is negative. John Neff might see a big relative performance advantage.
25.00%
Positive EPS growth while HUH1V.HE is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
25.00%
Positive diluted EPS growth while HUH1V.HE is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.58%
Share count expansion well above HUH1V.HE's 0.09%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.58%
Diluted share count expanding well above HUH1V.HE's 0.09%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-71.54%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-74.46%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-27.12%
Negative 10Y revenue/share CAGR while HUH1V.HE stands at 38.07%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
2.43%
5Y revenue/share CAGR under 50% of HUH1V.HE's 25.80%. Michael Burry would suspect a significant competitive gap or product weakness.
-15.16%
Negative 3Y CAGR while HUH1V.HE stands at 14.48%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
497.93%
Positive long-term OCF/share growth while HUH1V.HE is negative. John Neff would see a structural advantage in sustained cash generation.
-23.94%
Negative 5Y OCF/share CAGR while HUH1V.HE is at 180.64%. Joel Greenblatt would question the firm’s operational model or cost structure.
-15.81%
Negative 3Y OCF/share CAGR while HUH1V.HE stands at 177.77%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
143.23%
Net income/share CAGR above 1.5x HUH1V.HE's 90.61% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
650.00%
5Y net income/share CAGR above 1.5x HUH1V.HE's 67.71%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
66.67%
3Y net income/share CAGR above 1.5x HUH1V.HE's 38.99%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
52.10%
5Y equity/share CAGR 1.25-1.5x HUH1V.HE's 40.81%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
10.56%
Below 50% of HUH1V.HE's 22.25%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 5Y dividend/share CAGR while HUH1V.HE stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
No Data
No Data available this quarter, please select a different quarter.
18.92%
AR growth well above HUH1V.HE's 1.53%. Michael Burry fears inflated revenue or higher default risk in the near future.
3.95%
Inventory growth well above HUH1V.HE's 6.29%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
3.61%
Asset growth above 1.5x HUH1V.HE's 0.26%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-2.92%
We have a declining book value while HUH1V.HE shows 0.86%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
7.18%
Debt growth far above HUH1V.HE's 0.84%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-100.00%
Our R&D shrinks while HUH1V.HE invests at 6.38%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-3.68%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.